September 21-22, 2017
San Antonio, Texas, USA
We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.
Tesfaye Belay
Bluefield State College USA
Wei Huang
BD Life Sciences USA
Reza Nassiri
Michigan State University USA
Mandy J. Hill
UT Health Medical School USA
Solomon Nfor
St. Philip’s College USA
Lorece Edwards
Morgan State University USA
Maurice Mongkuo
Fayetteville State University USA
Pulsus Group invites all members around the world to attend “International Conference on Sexually Transmitted Diseases, HIV/AIDS & Parasitic Infections” on September 21-22, 2017 San Antonio, USA. The main theme focuses on Towards a cure: Approaches for transforming healthier communities
The main goals and Objectives of this conference include
Bringing together the world’s experts to advance knowledge about HIV, present new research findings, and promote and enhance scientific and community collaborations around the world.
Promoting HIV responses that are supported by and tailored to the needs of at risk populations or people living with HIV, including women and girls, men who have sex with men, transgender people, sex workers, young people, and people who use drugs
Building innovative partnerships with businesses, community, government, and science to strengthen HIV prevention and treatment efforts. Bring together diverse leaders and constituents.
Promoting activism and community mobilization that holds leaders, industry, and governments accountable and increases their commitment to an evidence-based, human-rights-affirming HIV and AIDS response
Advancing a clear agenda for HIV, including the cross-cutting issues of criminalization, gender-based violence, sexual and reproductive health, rights, and stigma and discrimination that keep people living with HIV at the center of the HIV response
Target Audience:
The target audience for this event are physicians and nurses with a special emphasis on infectious diseases, public health professionals, community health educators, members of academia, and other allied health professionals. Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers, academia, students, researchers, faculty, STD-AIDS associations and societies.
The Global market of HIV/AIDS according to the Financial Times 2015, was around USD 20 billion in 2013 and is estimated to reach 1.2 billion tests worth US$5.9 billion by 2020. The annual deaths from HIV/AIDS have fallen from 2.3 million in 2005 to 1.5 million in 2013, according to the UN AIDS report.
The global HIV diagnostics market was valued at USD 2,173.8 million in 2014 and is expected to grow at a CAGR of 9.5% over the forecast period. This expected increase in the number of product offerings to the global market space is expected to fuel the growth of the HIV diagnostics industry over the forecast period. The global HIV/AIDS market, including branded products and generics, was valued at $11.3 billion in 2010.
Growing demographics and economies in the developing countries such as India and China is expected to lead the growth in HIV-AIDS testing market in Asia. Increasing number of HIV patients, technological advancement in HIV-AIDS diagnosis, increasing incidence of infectious diseases, rise in research activities for developing HIV vaccines and lack of awareness about the modes of transmission of the virus are expected to drive the market for HIV-AIDS testing.
The North American HIV market is the highest market globally, by value and occupies more than 50% of the global revenue generated from HIV antiviral; this is followed by the European market at around 30% of the global market. The Asian, African and South American region contribute less than 20% share in the global HIV market.
The Global HV-AIDS testing market is characterized by increasing number of companies involved in the research and development of new products. Worldwide healthcare companies are ensuring to lower their costs in this region so that they can introduce their products to generic competition.
Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India has acquired Andrew John Publishing and openaccessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.
Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.
With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of Paediatrics Intensive and Critical Care Societies, World Association of Medical Sciences, International Society for Ceramics in Medicine, Thalassaemia International Federation and World Association of Integrated Medicine to nurture the research and development for the beneficence of society.
Since many years Pulsus has also been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international conferences and meetings.
